WHO/Christopher Black
© Credits

Strengthening access to essential medicines

WHO maintains its Model Lists of Essential Medicines and Essential Medicines for Children as part of the campaign for universal health coverage around the world. Currently in the 22nd and 8th editions, respectively, the lists are available to national and regional governments to help them create and update national essential medicines lists to guide procurement and supply of essential medicines at the national and local levels.

WHO promotes universal access to health products by reinforcing their selection and supply chains, supporting research and development for new health projects, and working to remove barriers to health services, particularly in low-income areas.

WHO works with governments to create strategies for measuring, monitoring and managing medicine prices that fit regional contexts and health care systems. This includes supporting countries to create evidence-based policies, building tools to monitor and measure programs, and promoting oversight of health care delivery.

208

essential medicines

The first WHO essential medicines list in 1977 identified 208 individual drugs.

1st List 1977

479

essential medicines

For meeting the priority health care needs of the population

22nd List 2021

350

essential medicines

For the priority health needs of children up to 12 years of age

8th List 2021

Feature Story

Biosimilars: expanding access to essential biologic therapies

WHO Expert Committee

Selection and Use of Essential Medicines

Events

Twenty-fifth Expert Committee on Selection and Use of Essential Medicines

5 – 9 May 2025
20 Avenue Appia - CH-1211 Geneva 27, Geneva, Switzerland

Digital Library

National EMLs

Infographic

Access_medicine

Revolutionizing access to medicines across the globe

The WHO model list of essential medicines has played a central role in mitigating the most damaging effects of HIV, and other diseases as well.
What the WHO Secretariat delivered

Our work

Publications

All →

Journal Artcles

All →
Instructions for applicants preparing a submission for the 2025 meeting of the WHO Expert Committee on Selection and Use of Essential Medicines
This document describes the mandatory format and key information requirements for submissions for the inclusion of new medicines and for inclusion of new...
The selection and use of essential medicines (2023) - TRS 1049

The 24th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 24 to 28 April 2023. The...

Revising the procedures for updating WHO’s model lists of essential medicines: consultation report, Geneva, Switzerland, 2-3 November 2023

First published in 1977 and updated every two years, the WHO Model List of Essential Medicine serves as a guide for countries or regional authorities to...